Treatment of tinnitus with a customized, dynamic acoustic neural stimulus: underlying principles and clinical efficacy.
Tinnitus has been challenging to treat with consistently positive results. The Neuromonics Tinnitus Treatment is a newly available approach to the treatment of clinically significant, problematic tinnitus (and reduced sound tolerance) that was developed with the intention of simultaneously addressing the auditory, attentional, and emotional processes underlying the condition. It uses a prescribed acoustic stimulus, customized for each patient's individual audiometric profile, which provides a broad frequency stimulus to address the effects of auditory deprivation, promotes relief and relaxation with the intention of reducing engagement of the limbic system/amygdala and autonomic nervous system, and applies the principles of systematic desensitization to address the attentional processes. This article describes the underlying principles behind this approach. It also summarizes evidence for clinical efficacy from controlled clinical studies and from a private practice clinical setting, where it has been shown to provide consistently positive outcomes for patients meeting suitability criteria.
Hanley
Peter J
PJ
Neuromonics Pty Limited, Chatswood, New South Wales, Australia. peter.hanley@neuromonics.com
Davis
Paul B
PB
D000161:Acoustic Stimulation / Q000379:methods*; D003056:Cochlear Nerve / Q000502:physiology*; D006801:Humans; D014012:Tinnitus / Q000628:therapy*; D016896:Treatment Outcome